Input 2020.12.31 14:08
–
This is the first time that the Chinese government has approved the use of the corona vaccine for the general public. The vaccine is still in phase 3 clinical trials. Normally, approval for the use of the vaccine is made after all clinical trials have been completed, but this time, a decision was made conditionally to respond to an emergency called Corona, the health authorities said.
However, health authorities did not disclose specific data on the efficacy of this vaccine. BBPI cited the interim results on the day, saying, “The effect of protecting people from disease is 79.34%.” If this data is true, the efficacy of the vaccine developed by Pfizer and Moderna in the United States is somewhat inferior compared to the more than 90% effective vaccine.
The Chinese government did not approve general use of the vaccine so far, but it granted emergency use in July, allowing essential workers and high-risk groups to be vaccinated in clinical trials. By the end of November, two vaccines developed by CNBG and one vaccine developed by another pharmaceutical company Sinobac were administered to about 1.5 million people.
–
– .
